Yahoo Web Search

Search results

    • AbbVie Completes Acquisition of Landos Biopharma

      The Longview News-Journal· 1 day ago

      With the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like ...

    • 2 Billion More Reasons to Buy AbbVie Stock

      2 Billion More Reasons to Buy AbbVie Stock

      Motley Fool via Yahoo Finance· 3 days ago

      According to Fortune Business Insights, the market for antidepressants will grow to reach $18.2 billion by 2027. Overall, the partnership is bullish for ...

    • 10 Stocks to Build a Dividend Portfolio With

      10 Stocks to Build a Dividend Portfolio With

      Motley Fool via Yahoo Finance· 7 days ago

      The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor returns as of May 13, 2024 Suzanne Frey, an...